Skip Navigation
Polsinelli's logo
  • Search
  • Our People
  • Our Capabilities
  • About Us
  • Alumni Network
  • Careers
  • Insights
    • News
    • Publications
    • Events
    • Blogs & Podcasts
  • Offices & Locations
  • Our Diverse Culture
  • Client Login
  • Contact Us

Christopher P. Simpson

Shareholder
he / him / his
  • Biography
  • Matters
  • News
  • Publications

News

April 14, 2026 Deals & Cases
Polsinelli Represents Alloy in ASO Platform Collaboration with Biogen
February 27, 2026 Deals & Cases
Chris Simpson and Team Advise Sanacor Inc. on its Collaboration Agreement with Chemify to Develop Small Molecule Therapies for Cardiometabolic Diseases
November 20, 2025 Deals & Cases
Polsinelli Advises Wirespeed on Sale to Coalition
November 19, 2025 Deals & Cases
Polsinelli Represents La La Land Kind Café, LLC in New Investment Round
September 17, 2025 Deals & Cases
Polsinelli Represents Trially Inc. in $4.7M Series Seed Financing
April 18, 2025 Deals & Cases
Polsinelli Represents iOR Holdings, Inc. in Series D Financing
February 18, 2025 Deals & Cases
Polsinelli Represents Sanacor, Inc. in Seed Financing
February 03, 2025 Deals & Cases
Polsinelli Represents Lula Smarter Property Maintenance, Inc. in $28 Million Series A Financing
September 26, 2024 Deals & Cases
Polsinelli Represents Ritual Zero Proof Non-Alcoholic Spirits in its Acquisition by Diageo North America
April 06, 2023 News
Polsinelli Represents Plant Pathways in Private Placement Financing
April 05, 2023 News
Polsinelli Represents Transportant Inc. in $3.2 Million Series A Financing
Biography
Matters
News
Publications
Firm Highlights
Slide 1 of 6
  • Publication
    Federal Circuit Finds Method-of-Treatment Claims Including In Vivo Dosing Limitations Are Not Enabled By In Vitro Data
    In Wyeth LLC v. AstraZeneca Pharmaceuticals LP, the Federal Circuit affirmed judgment as a matter of law that Wyeth's method-of-treatment claims were invalid for lack of enablement, wiping out a $107.5 million jury verdict over AstraZeneca's Tagrisso®. 
    Read more
  • Event
    When Websites Become Litigation Targets | Digital Risk and Innovation Summit Series
    Websites can be valuable business assets, but their public availability makes them easy targets for litigation. 
    Read more
  • Blog
    New York State is Set to Impose New Requirements for Separation Agreements
    Read more
  • Event
    Doctor, Doctor, Give Me the News | Hot Town, Summer in the City: What the Washington is Going On?! - Webinar Series
    Join Polsinelli's public policy team for a three-part lunch and learn series to hear what they’re watching in federal oversight and health care policy this season.
    Read more
  • Publication
    2027 OPPS Proposed Rule: Mandatory Provider-Based Attestations Signal a New Compliance Era
    Last week, the Centers for Medicare & Medicaid Services (CMS) published proposed rules mandating the submission of provider-based attestations for off-campus hospital outpatient departments as part of the 2027 Outpatient Prospective Payment System (OPPS) Proposed Rule (Proposed Rule). 
    Read more
  • News
    Polsinelli Adds Timothy Ayotte in Boston, Strengthening Life Sciences Corporate & Transactional Capabilities
    Polsinelli is pleased to announce that Timothy Ayotte has joined the firm as a shareholder in its Boston office, strengthening the firm’s corporate and transactional depth for life sciences, biotechnology and health care companies. 
    Read more
Follow us on LinkedInFollow us on Instagram
© 2026 Polsinelli. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Contact UsSubscribeAlumni NetworkCollaborate PolsinelliClient Payment PortalDisclaimerCookie PreferencesPrivacy Notice